<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (ARVD) is an inherited <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and is also called ARVD/C </plain></SENT>
<SENT sid="1" pm="."><plain>In most cases, ARVD is inherited in an <z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> pattern and clinically is characterized by <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> with an increased risk of <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Although it is prominently a disease of the right ventricle (RV), involvement of the left ventricle is not uncommon </plain></SENT>
<SENT sid="3" pm="."><plain>Pathologically, there is RV myocardial <z:mpath ids='MPATH_127'>atrophy</z:mpath> with thinning of the wall, <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, and global RV <z:mpath ids='MPATH_66'>dilatation</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Genetic testing and magnetic resonance imaging of the RV are an increasing aspect of the diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>Diagnosis relies on a scoring system with major or minor criteria </plain></SENT>
<SENT sid="6" pm="."><plain>Prevention of <z:hpo ids='HP_0001699'>sudden death</z:hpo> is the primary goal of management </plain></SENT>
<SENT sid="7" pm="."><plain>Pharmacologic treatment of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, catheter ablation of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, and implantable cardioverter defibrillator are the mainstay of treatment of ARVD/C </plain></SENT>
</text></document>